Surgical and orthopaedic medtech
Stryker Corporation
Stryker sells surgical equipment, patient-care systems, neurovascular products, orthopaedic implants, and Mako robots to hospitals and clinicians. It spends on enterprise software and cloud infrastructure used to operate its medical technologies and expands its vascular portfolio through acquisitions.
SYK Updated Sep 11, 2026 3 AI consumers· 2 recurring
Per the valuechain.wiki graph, Stryker Corporation is directly linked to 4 companies (3 supply, 1 revenue relationships) and reaches 41 companies within two hops; the links are backed by 9 dated sources, 2 of them primary filings (as of 2026-09-11).
Financials & Segments
- Total revenue · FY2025 total revenue: $25.116 billion (SEC Form 10-K, filed 2026-02-11)
- Segments · MedSurg and Neurotechnology · Orthopaedics
Revenue from
- HCA Healthcare High confidence
HCA Healthcare uses Stryker Sustainability Solutions for single-use medical-device reprocessing across its hospital network. It is a recurring service relationship with a major hospital chain, but Stryker does not disclose counterparty-level revenue. - Vizient, Inc. High confidence
Stryker supplies orthopaedic consumables and surgical equipment to hospital members through competitively awarded Vizient GPO agreements. Multiple product categories use this channel, but Stryker does not disclose total revenue routed through Vizient.Confirms EN Jackson Health System Public Health Trust Published Nov 29, 2023: Public Health Trust Board of Trustees One-Day Committee Meetings Agendas, November 29, 2023
Pays to
- Microsoft Medium confidence
Stryker uses integrated Microsoft technology for medical-device data and Smart Equipment Management. It does not disclose its spending with Microsoft. - Amazon Medium confidence
Vocera Edge and Vocera Ease, services provided by Stryker's wholly owned Vocera subsidiary, run on AWS infrastructure. Stryker does not disclose its AWS spending. - Alphabet (Google) Medium confidence
The care.ai platform, which Stryker acquired in 2024, is hosted on Google Cloud Platform. Stryker does not disclose its GCP spending.
Investments
- Inari Medical, Inc. High confidence· Amount $4.8B · 2025-02-19 acquisition · Purchase price for Inari Medical, net of cash acquired
Stryker acquired venous thromboembolism device maker Inari Medical in February 2025. Net cash consideration was $4.81 billion, and the business joined Peripheral Vascular within MedSurg and Neurotechnology.Confirms KO Mirae Asset Securities Research Center Published Mar 4, 2025: Monthly Research: Global Healthcare PrescriptionConfirms EN Stryker Investor Relations Published Feb 19, 2025: Stryker Completes Acquisition of Inari Medical, Inc.
Value-chain ripple (2 tiers)
Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.
| Company | Chain | '21 | '22 | '23 | '24 | '25 | YTD |
|---|---|---|---|---|---|---|---|
| HCA Healthcare, Inc. | lead1 | +57.6 | -5.6 | +13.8 | +11.8 | +56.7 | -12.9 |
| Stryker Corporation | node | +10.2 | -7.4 | +23.8 | +21.3 | -1.5 | -13.3 |
| Alphabet (Google) | benef1 | +65.3 | -39.1 | +58.3 | +36 | +66 | +8.3 |
| Microsoft | benef1 | +52.5 | -28 | +58.2 | +12.9 | +15.6 | +4 |
| Seagate Technology | benef2 | +87.5 | -51.4 | +69.1 | +4.1 | +225.3 | +209.1 |
| Western Digital | benef2 | +17.7 | -51.6 | +66 | +13.9 | +283.7 | +171.6 |
| Marvell | benef2 | +84.6 | -57.5 | +63.7 | +83.8 | -22.8 | +163.4 |
| Intel | benef2 | +6.1 | -46.6 | +94.6 | -59.6 | +84 | +159.6 |
| AMD | benef2 | +56.9 | -55 | +127.6 | -18.1 | +77.3 | +123 |
| Wiwynn | benef2 | +24.7 | -22.3 | +206.4 | +3.5 | +64.4 | +120.2 |
| Astera Labs | benef2 | · | · | · | · | +25.6 | +86.6 |
| Flex Ltd. | benef2 | +1.9 | +17.1 | +41.9 | +67.2 | +57.4 | +81.2 |
| Vertiv | benef2 | +33.8 | -45.3 | +251.8 | +136.8 | +42.8 | +73.2 |
| Arista Networks | benef2 | +97.9 | -15.6 | +94.1 | +87.7 | +18.5 | +47.9 |
| Occidental Petroleum | benef2 | +67.7 | +119.1 | -4.1 | -15.9 | -14.9 | +47.4 |
| GE Vernova | benef2 | · | · | · | · | +99 | +44.4 |
| TeraWulf | benef2 | +77.1 | -95.5 | +258.2 | +135.8 | +103 | +43.7 |
| Caterpillar | benef2 | +16 | +18.6 | +25.9 | +24.7 | +60.3 | +42.9 |
| Ciena | benef2 | +45.6 | -33.8 | -11.7 | +88.4 | +175.8 | +37.3 |
| Equinix | benef2 | +20.3 | -21.1 | +25.4 | +19.5 | -16.9 | +37.3 |
| Alchip Technologies | benef2 | +14.3 | -8.7 | +365.1 | -18.9 | +0.8 | +36.1 |
| Super Micro | benef2 | +38.8 | +86.8 | +246.2 | +7.2 | -4 | +35.3 |
| Eaton | benef2 | +46.7 | -7.2 | +56.2 | +39.5 | -2.8 | +30.1 |
| Quanta Computer | benef2 | +22.2 | -12.8 | +254.5 | +12.7 | +8.9 | +28.5 |
| NVIDIA | benef2 | +125.5 | -50.3 | +239 | +171.2 | +38.9 | +23.7 |
| Schneider Electric | benef2 | +25.9 | +1.6 | +25.8 | +36.1 | +0.5 | +20.7 |
| Foxconn (Hon Hai) | benef2 | -5.1 | +2.8 | +7.8 | +80.1 | +26.9 | +19.6 |
| Credo Technology | benef2 | · | · | +46.3 | +245.2 | +114.1 | +18.5 |
| IREN | benef2 | · | -92.3 | +472 | +37.3 | +284.6 | +18.3 |
| Cummins | benef2 | -1.7 | +14.1 | +1.7 | +48.9 | +49.4 | +11 |
| Automatic Data Processing, Inc. | benef2 | +42.6 | -1.3 | -0.2 | +28.4 | -10.2 | +9.6 |
| 3M Company | benef2 | +4.9 | -29.6 | -3.3 | +46.1 | +26.4 | +6.8 |
| NextEra Energy | benef2 | +23.4 | -8.5 | -25.3 | +21.5 | +15.5 | +6.2 |
| Xcel Energy | benef2 | +4.4 | +6.4 | -8.7 | +12.3 | +13.9 | +4.1 |
| Berkshire Hathaway | benef2 | +29 | +3.3 | +15.5 | +27.1 | +10.9 | +0.7 |
| Brookfield Asset Management Ltd. | benef2 | · | · | +45.6 | +39.7 | -0.2 | -0.4 |
| Comcast Corporation | benef2 | -2.2 | -28.7 | +29.1 | -11.8 | -17.3 | -1.9 |
| IonQ | benef2 | · | -79.3 | +259.1 | +237.1 | +7.4 | -11.9 |
| Constellation Energy | benef2 | · | · | +37.2 | +92.7 | +58.8 | -15 |
| Take-Two Interactive Software, Inc. | benef2 | -14.5 | -41.4 | +54.6 | +14.4 | +39.1 | -16.1 |
YTD as of 2026-09-04 · source: Yahoo Finance
Stryker Corporation operates across Surgical and orthopaedic medtech. It remained weak at -1.5% in 2025 and -13.3% in 2026. The supply side (avg +8.1%) leads the stock (-13.3%), with spending rippling down to suppliers first. Among connected nodes the furthest ahead is Amazon (+12%) and the furthest behind is Microsoft (+4%). If chain logic explains the gap, the laggard is the next propagation candidate; if not, the link itself deserves a second look. It spends on enterprise software and cloud infrastructure used to operate its medical technologies and expands its vascular portfolio through acquisitions.
Analysis generated from returns as of 2026-09-04